1. The synergistic inhibition of breast cancer proliferation by combined treatment with 4EGI-1 and MK2206
   Hongtao Wang et al, 2015, Cell Cycle CrossRef
2. SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma
   Qian Chen et al, 2018, World Journal of Surgical Oncology CrossRef
3. Endothelial ARHGEF26 is an angiogenic factor promoting VEGF signalling
   Qiuyu Martin Zhu et al, 2022, Cardiovascular Research CrossRef
4. Comprehensive Transcriptomic and Proteomic Analyses Identify a Candidate Gene Set in Cross-Resistance for Endocrine Therapy in Breast Cancer
   Chung-Liang Li et al, 2022, International Journal of Molecular Sciences CrossRef
5. Investigation of androgen receptor-dependent alternative splicing has identified a unique subtype of lethal prostate cancer
   Sean Seltzer et al, 2023, Asian Journal of Andrology CrossRef
6. SGEF enhances EGFR stability through delayed EGFR trafficking from early to late endosomes
   H. Wang et al, 2013, Carcinogenesis CrossRef
7. Tyrosine Phosphorylation of SGEF Regulates RhoG Activity and Cell Migration
   Yusuke Okuyama et al, 2016, PLOS ONE CrossRef
8. Grb2 interacts with SGEF and antagonizes the ability of SGEF to enhance EGF-induced ERK1/2 activation
   Hongtao Wang et al, 2014, Molecular and Cellular Biochemistry CrossRef
9. Cryptotanshinone inhibits breast cancer cell growth by suppressing estrogen receptor signaling
   Shanhu Li et al, 2015, Cancer Biology & Therapy CrossRef
10. A Highly Accurate Model for Screening Prostate Cancer Using Propensity Index Panel of Ten Genes
    Shipra Jain et al, 2023, Journal of Computational Biology CrossRef
11. Dicer generates a regulatory microRNA network in smooth muscle cells that limits neointima formation during vascular repair
    Farima Zahedi et al, 2017, Cellular and Molecular Life Sciences CrossRef
12. Novel 3‐D cell culture system for in vitro evaluation of anticancer drugs under anchorage‐independent conditions
    Ayako Aihara et al, 2016, Cancer Science CrossRef